Genentech/MedImmune Patent Case Could Spur Tighter Licensing Deals
Supreme Court ruling that MedImmune can challenge the validity of a patent it had licensed could also encourage generic firms to seek declaratory judgments.
Supreme Court ruling that MedImmune can challenge the validity of a patent it had licensed could also encourage generic firms to seek declaratory judgments.